Home Cart Sign in  
Chemical Structure| 1401728-56-0 Chemical Structure| 1401728-56-0

Structure of NE 52-QQ57
CAS No.: 1401728-56-0

Chemical Structure| 1401728-56-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NE 52-QQ57 is a selective, and orally available GPR4 antagonist with an IC50 of 70 nM. NE 52-QQ57 has anti-inflammatory activity.

Synonyms: NE 52-QQ57

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NE 52-QQ57

CAS No. :1401728-56-0
Formula : C24H28N6O
M.W : 416.52
SMILES Code : CC1=CC(C)=NC2=C(CC3=CC=C(C4=NN=C(C5CCNCC5)O4)C=C3)C(CC)=NN12
Synonyms :
NE 52-QQ57
MDL No. :MFCD31813600
InChI Key :HXPQWNPLNIEJOW-UHFFFAOYSA-N
Pubchem ID :68379135

Safety of NE 52-QQ57

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of NE 52-QQ57

GPCR

Isoform Comparison

Biological Activity

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice DSS-induced acute colitis model Oral gavage 30mg/kg Twice daily for 7 days To evaluate the anti-inflammatory effects of GPR4 antagonist 13 in the DSS-induced acute colitis model. Results showed that GPR4 antagonist 13 significantly alleviated colonic inflammation, reducing clinical symptoms and macroscopic disease indicators such as body weight loss, fecal score, colon shortening, mesenteric lymph node expansion, and splenic enlargement. Eur J Pharmacol. 2019 Jun 5;852:218-230

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.40mL

0.48mL

0.24mL

12.00mL

2.40mL

1.20mL

24.01mL

4.80mL

2.40mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories